Renalytix Ai Plc-adr logo

Renalytix Ai Plc-adr Share Price (NASDAQ: RNLX)

Live

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 4 Oct 2024

Check the interactive Renalytix Ai Plc-adr Stock chart to analyse performance

Renalytix Ai Plc-adr Key Stats

Check Renalytix Ai Plc-adr key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.0
Open
$0.189
Market Capitalization
$18.2M
Today's Volume
$866.5K
Revenue TTM
$2.3M
EBITDA
$-28.6M
Earnings Per Share (EPS)
$-0.62
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1073.18%

Global Institutional Holdings in Renalytix Ai Plc-adr

  • Name

    Holdings %

  • Pinnacle Associates Inc

    0.98%

  • Stifel Financial Corp

    0.68%

  • Easterly Investment Partners.

    0.67%

  • Tejara Capital Ltd

    0.60%

  • CI Private Wealth LLC

    0.40%

  • Nantahala Capital Management, LLC

    0.28%

Analyst Recommendation on Renalytix Ai Plc-adr Stock

Rating
Trend

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 5 Wall street analysts offering stock ratings for Renalytix Ai Plc-adr(by analysts ranked 0 to 5 stars)

About Renalytix Ai Plc-adr

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix Plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; and Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers. The company also has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is based in New York, New York.
Organization
Renalytix Ai Plc-adr
Employees
0
CEO
Mr. James R. McCullough M.B.A.
Industry
Technology Services

Important FAQs about investing in RNLX Stock from India :

What is Renalytix Ai Plc-adr share price today?

Renalytix Ai Plc-adr share price today is as on . Renalytix Ai Plc-adr share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Renalytix Ai Plc-adr share?

Renalytix Ai Plc-adr share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Renalytix Ai Plc-adr stock price today i.e. is trending at , lower by 100% versus the 52 week high.

How to invest in Renalytix Ai Plc-adr Stock (RNLX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Renalytix Ai Plc-adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Renalytix Ai Plc-adr Shares .

What is the minimum amount required to buy Renalytix Ai Plc-adr Stock (RNLX) from India?

Indian investors can start investing in Renalytix Ai Plc-adr (RNLX) shares with as little as ₹88.651 or $1 (as of November 06, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹886.51 in Renalytix Ai Plc-adr stock (as per the Rupee-Dollar exchange rate as on November 06, 2025). Learn more about fractional shares .

What are the returns that Renalytix Ai Plc-adr has given to Indian investors in the last 5 years?

Renalytix Ai Plc-adr stock has given 0.0% share price returns and 19.91% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?